BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge

SIMPLE SUMMARY: Metastatic melanoma is the most lethal skin cancer due to its high metastatic potential and resistance to treatment. The advent of targeted therapies has improved patient management. However, due to the emergence of resistance shortly after the start of treatment, the overall and pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Florent, Laetitia, Saby, Charles, Slimano, Florian, Morjani, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177463/
https://www.ncbi.nlm.nih.gov/pubmed/37174072
http://dx.doi.org/10.3390/cancers15092607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177463/
https://www.ncbi.nlm.nih.gov/pubmed/37174072
http://dx.doi.org/10.3390/cancers15092607

Ejemplares similares